There is no widely published net worth figure for Salvatore Viscomi as of May 2026. The most credible public figure matching this name is Salvatore G. Viscomi, MD, CEO and co-founder of Carna Health, a digital health company focused on chronic kidney disease (CKD) management. Based on his executive role at an early-to-mid-stage health-tech startup, Forbes Technology Council membership, and the typical compensation and equity structure for founders in that space, a reasonable estimated net worth range is $1 million to $10 million, with the figure heavily dependent on Carna Health's current valuation and any funding rounds completed to date. That range reflects informed estimation, not a verified disclosure, and should be treated accordingly.
Salvatore Viscomi Net Worth: Estimate, Sources, and How It’s Calculated
First, a quick disambiguation: which Salvatore Viscomi are we talking about?
Searching for 'Salvatore Viscomi' surfaces at least two distinct individuals. The first is a Miami Beach-based professional with a LinkedIn presence connecting him to XLS Realty and roughly 20 years of restaurant ownership and management experience. The second is Salvatore G. Viscomi, MD, a physician-entrepreneur who co-founded Carna Health and currently serves as its CEO. These are two different people, and conflating them would produce a completely meaningless net worth estimate.
The healthcare version, Salvatore G. Viscomi MD, is the one generating recent, credible public documentation. His profile appears on the Carna Health leadership page, and a Forbes Technology Council profile published in early 2026 identifies him specifically as 'CEO and cofounder of Carna Health.' That level of verifiable public record makes him the clearest candidate for a net worth profile. The Miami Beach real-estate and restaurant figure has a much smaller public footprint and no published financial data worth analyzing. This article focuses on Salvatore G. Viscomi, MD, unless otherwise noted.
Who is Salvatore G. Viscomi, MD?
Salvatore G. Viscomi is a physician and health-tech entrepreneur best known for co-founding Carna Health, a digital health platform targeting chronic kidney disease. CKD affects roughly 37 million Americans, making it one of the largest underserved markets in healthcare. Carna Health positions itself as a technology-enabled care management solution within that space, which places it in the high-growth intersection of value-based care and remote patient monitoring. Viscomi holds both a medical degree and an executive leadership role, a combination that typically commands significant equity in health-tech ventures. He is also listed as a member of the Forbes Technology Council, a vetted professional community for senior technology executives, which adds credibility to his standing in the broader health-tech industry.
Where his wealth likely comes from
For a physician-founder in a funded health-tech startup, wealth accumulates through a few distinct channels. Viscomi's likely income and asset streams break down as follows.
- Founder equity in Carna Health: Co-founders of early-stage health-tech companies typically retain 10% to 30% of a company before dilution from funding rounds. If Carna Health has raised venture capital or private equity backing, Viscomi's ownership stake would have been partially diluted but still represents the largest single driver of his estimated net worth.
- CEO salary: Physician-CEOs at funded health-tech startups typically earn between $200,000 and $400,000 annually in base compensation, often supplemented by performance bonuses. This is modest by Fortune 500 standards but substantial compared to most career paths.
- Clinical income: Many physician-founders continue limited clinical practice while running their companies. If Viscomi maintains any active clinical hours, this adds a supplemental income stream, though it is likely secondary to his executive role.
- Advisory and board roles: His Forbes Technology Council membership and health-tech profile suggest he may hold advisor or board positions at other companies, which typically come with equity grants or consulting fees.
- Speaking, media, and thought leadership: Physician-entrepreneurs in recognized councils like Forbes Technology Council often generate income from speaking engagements, interviews, and consulting, though this is rarely a primary wealth driver.
Asset and portfolio breakdown
Without public filings or a disclosed balance sheet, the asset breakdown is necessarily estimated from what we know about his career stage and industry norms. Here is how his portfolio likely looks as of mid-2026.
| Asset Category | Estimated Range | Confidence Level |
|---|---|---|
| Carna Health equity stake | $500K – $8M+ | Low-to-medium (depends on valuation and dilution) |
| Cash and liquid savings | $200K – $600K | Medium (consistent with executive compensation history) |
| Real estate (primary residence) | $300K – $1M | Low (location and ownership status unknown) |
| Retirement accounts and investments | $100K – $500K | Medium (standard for a physician in his career stage) |
| Advisory equity / other startups | $0 – $300K | Low (speculative; no public record of specific roles) |
The Carna Health equity position is by far the most volatile and consequential component. If the company completes a major funding round, achieves profitability, or moves toward an acquisition or IPO, that single asset could push his net worth well beyond the current estimate. Conversely, if the company is still pre-revenue or in early seed stages, the equity may have nominal rather than realized value.
How the wealth likely grew over time
Reconstructing a wealth timeline for Viscomi requires reading backward from what is publicly documented. Here is a plausible arc based on his career trajectory.
- Medical training and early clinical years: Like most physicians, Viscomi likely spent a significant portion of his 20s and early 30s in medical school, residency, and potentially fellowship training. Physicians carry substantial student debt during this period and accumulate little investable wealth until they begin practicing. Net worth during this phase: likely negative to near-zero.
- Clinical practice and savings accumulation: Once in active practice, physician incomes typically range from $200,000 to over $500,000 annually depending on specialty and setting. Over several years of practice, a disciplined physician can accumulate meaningful savings, retirement assets, and real estate equity. This phase likely built Viscomi's financial foundation.
- Founding Carna Health: The founding of Carna Health represents the inflection point. Taking on a co-founder role means accepting lower immediate cash compensation in exchange for equity upside. This is a deliberate wealth-concentration bet: less liquidity now, potentially much more later. The founding date is not precisely documented publicly, but his current CEO role and Forbes Technology Council listing as of early 2026 suggest the company has been operating for at least a few years.
- Growth and fundraising: As Carna Health raised funding and built out its platform, each round would have established a company valuation, giving Viscomi's equity a paper value even before any exit. Forbes Technology Council membership in 2026 signals the company has achieved enough credibility and scale to position its CEO as a recognized technology leader.
- Current status (May 2026): Viscomi appears to be in an active growth phase as CEO, with the company publicly visible and his leadership role documented across multiple credible platforms. His net worth at this stage reflects accumulated clinical savings plus unrealized startup equity, not yet a liquidity event.
Why net worth estimates vary and how this one was built
Net worth estimates for private individuals like Viscomi are inherently imprecise, and it is worth being honest about why. Unlike public company executives who must disclose compensation in SEC filings, or celebrities whose contracts sometimes leak, private startup founders rarely have their finances documented in accessible public records. The estimate in this article is built from industry benchmarks, career stage analysis, and the limited public record available, not from any direct financial disclosure.
Several factors create variance in any estimate. Carna Health's capitalization table, funding history, and current valuation are not publicly disclosed. Viscomi's personal real estate holdings, if any, are not documented in public property records that have surfaced in this research. His clinical practice status is unclear, so the income from any medical work is unknown. And any advisor equity positions he holds at other companies would add to his total but are not documented publicly. This is why the range given ($1 million to $10 million) is intentionally wide. A narrower number would imply precision that the available data simply does not support.
It is also worth noting the disambiguation issue again: if you encounter a net worth figure attributed to 'Salvatore Viscomi' somewhere online and it references restaurant ownership or Miami real estate without any mention of healthcare or Carna Health, that figure likely refers to the other individual with this name. If you come across a number for Dominic Visconsi net worth, it is best to confirm whether it refers to a different person with a similar name before relying on it Salvatore Viscomi. The two profiles are distinct, and mixing them would produce a meaningless composite number.
For context, this type of estimation challenge is common across net worth profiles for private figures. Similar disambiguation issues arise with other names in this space, where multiple individuals share a name and search traffic mixes their identities.
How to verify or update this estimate today
If you want to track Viscomi's net worth more precisely over time, here are the most useful sources and signals to monitor.
- Carna Health funding announcements: Any Crunchbase, PitchBook, or press release announcing a funding round for Carna Health will include an implied or explicit valuation, which directly affects the paper value of Viscomi's equity stake. Search 'Carna Health funding' or check Crunchbase.com directly.
- LinkedIn profile updates: Viscomi's LinkedIn history is a reliable signal of career moves, new board positions, or company milestones. New roles or advisor listings can hint at additional equity compensation.
- Forbes Technology Council and media profiles: His Forbes Technology Council profile, last noted as active in early 2026, may be updated with new company details or financial context. Any Forbes editorial feature (as opposed to council member content) would carry stronger editorial vetting.
- SEC EDGAR: If Carna Health ever pursues an IPO or files as a reporting company, executive compensation disclosures become public through EDGAR (sec.gov). This would be the most reliable source for a precise figure.
- State business registrations: Many states publish basic business registration data for LLCs and corporations. Searching for Carna Health in the state where it is incorporated may surface founding documents, registered agents, or officer names that confirm Viscomi's role and ownership structure.
- Property records: If you want to estimate his real estate holdings, tools like Zillow, Redfin, county assessor databases, or PACER can surface property ownership records linked to his name, though these require knowing his location.
- Red flags for unreliable estimates: Be skeptical of any site that lists a specific dollar figure for Viscomi without citing a source, referencing a funding round or salary disclosure, or acknowledging the ambiguity between the two public figures sharing this name. Round numbers like '$5 million' or '$2 million' with no supporting documentation are almost always extrapolations from industry averages, not actual data.
The clearest path to a more precise figure is a Carna Health funding announcement or acquisition. Until that happens, the $1 million to $10 million range, weighted toward the lower end absent a known liquidity event, remains the most defensible estimate available for Salvatore G. If you are searching for Salvatore Vulcano net worth, note that this article is focused on Salvatore G. Viscomi, MD, so the figures are not interchangeable $1 million to $10 million range. If you are trying to answer what is Sal Vulcano's net worth, note that this article covers Salvatore G. Viscomi, MD, not Sal Vulcano. Viscomi, MD as of May 2026.
FAQ
How can I verify I am looking at the right Salvatore Viscomi net worth?
The name alone is rarely enough. Confirm the person is Salvatore G. Viscomi, MD, by matching identifiers like his CEO and co-founder role at Carna Health and the medical designation in reputable profiles, then ignore any “net worth” pages that describe restaurant or Miami real estate unless they explicitly reference Carna Health.
Why is the net worth number for a private health-tech founder so hard to pin down?
For a private founder, “net worth” is mostly not a simple cash total, it is the value of illiquid equity plus any liquid assets like cash, investments, and property. Without a reported liquidity event (major secondary, acquisition, IPO), equity values should be treated as theoretical and often overestimated by generic net worth sites.
What specific events would most change Viscomi’s estimated net worth?
A more meaningful way to estimate is to wait for verifiable valuation signals, such as a documented funding round with share pricing, a SAFE-to-equity conversion, or an acquisition rumor confirmed by a company release. If those are missing, your estimate should remain a range, and you should bias it low if the company is still pre-revenue or early seed.
How does dilution from multiple funding rounds affect a founder’s net worth estimate?
Founder equity can be diluted across rounds, and option pools can further reduce ownership percentage even when headline valuations rise. If Carna Health has had multiple funding rounds, a static “founder stake” assumption can inflate net worth, so any tighter estimate should account for dilution and vesting terms.
Why might an impressive company valuation not translate to a high personal net worth immediately?
Even if there is a funding announcement, the personal wealth can be lower than expected if his equity is subject to vesting schedules, performance hurdles, or lockups. In practice, you cannot assume 100 percent of equity is immediately monetizable, so any “valuation times ownership” shortcut can be misleading.
Could other roles or compensation streams make his net worth higher than the main equity estimate suggests?
If Carna Health has partnerships, advisory roles, or board seats that are separate from his CEO stock, those can add to compensation and additional equity, but they will not show up in many public sources. A better approach is to scan for documented titles and compensation disclosures in official press releases or direct leadership bios, then separate that from equity-only assumptions.
What are common mistakes net worth sites make with this name?
Generic net worth websites often blend multiple people with the same name, reuse outdated numbers, or treat paper valuations as cash. A red flag is a lack of identity matching, no mention of Carna Health, or reliance on restaurant or real estate descriptions that do not align with the MD founder profile.
What signals should I monitor to update the estimate over time?
If you are trying to track changes over time, watch the cadence of funding announcements, product traction metrics that imply revenue readiness, and any leadership changes or executive departures. The net worth estimate should move mostly when liquidity or equity repricing becomes credible, not when market chatter increases.
